Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Yu

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Health and Quality of Life Outcomes|June 15, 2025
Optimal DCE design for modelling nonlinear time preferences in EQ-5D-5L valuation studies: exploration of data from Denmark and PeruAlice Yu, Deborah Street, Marcel Jonker, et al.
Journal of Proteomics|June 6, 2013
Transcriptomic and iTRAQ proteomic approaches reveal novel short-term hyperosmotic stress responsive proteins in the gill of the Japanese eel (Anguilla japonica)William Ka Fai Tse, Jin Sun, Huoming Zhang, et al.
Urologic Oncology|October 11, 2021
Clinical indications for necessary and discretionary hospital readmissions after radical cystectomyAhmet Murat Aydin, Richard R Reich, Biwei Cao, et al.
Cancers|March 13, 2025
Extracellular Microvesicle MicroRNAs and Imaging Metrics Improve the Detection of Aggressive Prostate Cancer: A Pilot StudyKapil K Avasthi, Jung W Choi, Tetiana Glushko, et al.
Journal of Pediatric Hematology/Oncology|May 14, 2005
Temozolomide and radiation for aggressive pediatric central nervous system malignanciesKenneth C Loh, Jennifer Willert, Hal Meltzer, et al.
Data in Brief|July 29, 2015
Data for transcriptomic and iTRAQ proteomic analysis of Anguilla japonica gills in response to osmotic stressWilliam Ka Fai Tse, Jin Sun, Huoming Zhang, et al.
BMC Geriatrics|August 9, 2024
High cardiovascular mortality risk among older merkel cell carcinoma patientsJia-Nan Huang, Hai Yu, Xichun Xia, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical ExtensionPrithvi B Murthy, Shreyas Naidu, Facundo Davaro, et al.
European Urology Oncology|July 16, 2025
Assessing the Impact of Treatment Timing Protocols in Clinical Trials for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerChristopher Guske, Seyed Behzad Jazayeri, Christian Harrs, et al.
BJU International|January 18, 2025
Response to neoadjuvant chemotherapy leads to better survival outcomes in upper tract urothelial carcinomaAlice Yu, Patrick J Hensley, Heather L Huelster, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Health and Quality of Life Outcomes|June 15, 2025
Optimal DCE design for modelling nonlinear time preferences in EQ-5D-5L valuation studies: exploration of data from Denmark and PeruAlice Yu, Deborah Street, Marcel Jonker, et al.
Journal of Proteomics|June 6, 2013
Transcriptomic and iTRAQ proteomic approaches reveal novel short-term hyperosmotic stress responsive proteins in the gill of the Japanese eel (Anguilla japonica)William Ka Fai Tse, Jin Sun, Huoming Zhang, et al.
Urologic Oncology|October 11, 2021
Clinical indications for necessary and discretionary hospital readmissions after radical cystectomyAhmet Murat Aydin, Richard R Reich, Biwei Cao, et al.
Cancers|March 13, 2025
Extracellular Microvesicle MicroRNAs and Imaging Metrics Improve the Detection of Aggressive Prostate Cancer: A Pilot StudyKapil K Avasthi, Jung W Choi, Tetiana Glushko, et al.
Journal of Pediatric Hematology/Oncology|May 14, 2005
Temozolomide and radiation for aggressive pediatric central nervous system malignanciesKenneth C Loh, Jennifer Willert, Hal Meltzer, et al.
Data in Brief|July 29, 2015
Data for transcriptomic and iTRAQ proteomic analysis of Anguilla japonica gills in response to osmotic stressWilliam Ka Fai Tse, Jin Sun, Huoming Zhang, et al.
BMC Geriatrics|August 9, 2024
High cardiovascular mortality risk among older merkel cell carcinoma patientsJia-Nan Huang, Hai Yu, Xichun Xia, et al.
Current Oncology (Toronto, Ont.)|March 28, 2023
Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical ExtensionPrithvi B Murthy, Shreyas Naidu, Facundo Davaro, et al.
European Urology Oncology|July 16, 2025
Assessing the Impact of Treatment Timing Protocols in Clinical Trials for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerChristopher Guske, Seyed Behzad Jazayeri, Christian Harrs, et al.
BJU International|January 18, 2025
Response to neoadjuvant chemotherapy leads to better survival outcomes in upper tract urothelial carcinomaAlice Yu, Patrick J Hensley, Heather L Huelster, et al.
Pageof 11